Remove Clinical Trials Remove DEA Remove Decriminalization Remove Recreational
article thumbnail

Psychedelic Revolution Version 2.0: Save Lives & Dismantle War on Fungus

NewsMunchies

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. Can I get in trouble for using psilocybin?

article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Published Via JD Supra. 360bbb-0a(a)(2).

Law 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis and International Trade: Never the Twain Shall Meet?

Canna Law Blog

Canada legalized recreational marijuana for the entire country. took significant steps to decriminalize or legalize medical or recreational marijuana. Although DEA’s approval of this importation may be just a one-off, this one approval could signal an eventual broader opening of the U.S. Many countries (e.g.,

article thumbnail

Reminder: These are the draft cannabis bills the House Energy and Commerce Subcommittee on Health Will Look At This Week

Cannabis Law Report

The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. 2843, Marijuana Freedom and Opportunity Act. 1151, Veterans Medical Marijuana Safe Harbor Act.